A technology for automated, pre-symptomatic screening for almost any biomarker-based risk event

Authors

The Centre of Excellence for the Prevention of Organ Failure, or PROOF Centre, and IO Informatics today announced a deal to develop a web-based software application addressing chronic heart, lung, and kidney disease.

Clinicians can use this application on handheld device and other technology, and will be used with blood tests developed by the PROOF Centre that target chronic disease and transplantation.

This application will give an overall score indicating patient risk level and associated clinical recommendations. The scores and recommendations will be based on gene expression data, protein expression data, and longitudinal clinical observations and certainly this will help guide decision making.

Erich Gombocz, vice president and chief science officer of Berkeley, Calif.-based Ion Informatics, said in a statement that future applications of the technology will allow for automated, pre-symptomatic screening for almost any biomarker-based risk event, disease severity characterization, and treatments that are patient-centric.

source

genomeweb

 

 

 

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: